Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Carcinoma, Papillary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04500925
What this trial is testing

The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience

Who this might be right for
Well Differentiated Thyroid CarcinomaPapillary Thyroid Cancer
Tel-Aviv Sourasky Medical Center 301
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Not applicableStudy completedNCT03300284
What this trial is testing

Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 186
Testing effectiveness (Phase 2)Study completedNCT01286753
What this trial is testing

Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Who this might be right for
Neoplasms
Hoffmann-La Roche 51
Not applicableUnknownNCT04031339
What this trial is testing

Study of Clinical Outcomes of Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
University of Roma La Sapienza 15,000
Not applicableNot Yet RecruitingNCT03813173
What this trial is testing

Central Cervical Dissection for Clinical Node Negative Papillary Thyroid Carcinoma

Who this might be right for
Lymph Node Metastases
Zhejiang University 6,000
Large-scale testing (Phase 3)Active Not RecruitingNCT01398085
What this trial is testing

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Who this might be right for
Thyroid CancerThyroid Neoplasms
University College, London 504
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Not applicableLooking for participantsNCT02609685
What this trial is testing

Active Surveillance of Papillary Thyroid Microcarcinoma

Who this might be right for
Papillary Thyroid Microcarcinoma
Cedars-Sinai Medical Center 216
Not applicableActive Not RecruitingNCT07314255
What this trial is testing

The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma

Who this might be right for
PTCI-131Trop2
Jiangxi Provincial Cancer Hospital 60
Not applicableStudy completedNCT02724176
What this trial is testing

Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Peking University Cancer Hospital & Institute 140
Not applicableUnknownNCT05446441
What this trial is testing

Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Zhejiang Provincial People's Hospital 634
Not applicableUnknownNCT04424485
What this trial is testing

Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy

Who this might be right for
Thyroid CancerThyroid Carcinoma, PapillaryThyroid Metastases+3 more
Umraniye Education and Research Hospital 100
Not applicableNot Yet RecruitingNCT07299318
What this trial is testing

Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer

Who this might be right for
Papillary Thyroid Carcinoma
West China Hospital 3,200
Not applicableNot Yet RecruitingNCT06899347
What this trial is testing

The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 cm Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaCentral Compartment Neck DissctionThyroidectomy+1 more
Leonardo Rossi 392
Testing effectiveness (Phase 2)Study completedNCT00287287
What this trial is testing

REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas

Who this might be right for
Thyroid Neoplasms
Kenneth Ain 25
Not applicableLooking for participantsNCT05766098
What this trial is testing

Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY

Who this might be right for
Papillary Thyroid Cancer
Istituto Auxologico Italiano 600
Large-scale testing (Phase 3)Study completedNCT00795782
What this trial is testing

Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Who this might be right for
Thyroid Cancer
Samsung Medical Center 258
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Not applicableActive Not RecruitingNCT06271044
What this trial is testing

A. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

Who this might be right for
to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm
Helsinki University Central Hospital 61
Next Page